Stelvio Therapeutics Companies
Stelvio Therapeutics is a privately held, biotechnology company based in San Diego, California that was founded in 2017 by Attila Hajdu. The company focuses on developing a pipeline of alternative treatments for malignant glioblastoma multiforme (GBM), the most common and lethal brain tumor.Stelvio Therapeutics - Wiki | Goldengolden.com/wiki/Stelvio_Therapeutics-4N9G4R8
Investors
Headquarters:
San Diego, San Diego County, California, United States
Founded Date:
2017
Employee Number:
11-50
Industry:
AI R&D Pharma (DPI)